PDB Short entry for 1DJP HEADER HYDROLASE 03-DEC-99 1DJP TITLE CRYSTAL STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE TITLE 2 INHIBITOR DON COVALENTLY BOUND IN THE ACTIVE SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMINASE-ASPARAGINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.1.38 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS SP.; SOURCE 3 ORGANISM_TAXID: 65406; SOURCE 4 STRAIN: 7A KEYWDS PGA, GLUTAMINASE, ASPARAGINASE, DON, 6-DIAZO-5-OXO-L-NORVALINE, KEYWDS 2 GLUTAMINASE-ASPARAGINASE, SUICIDE INHIBITOR, COVALENTLY BOUND KEYWDS 3 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.ORTLUND,M.W.LACOUNT,K.LEWINSKI,L.LEBIODA REVDAT 6 04-OCT-17 1DJP 1 REMARK REVDAT 5 13-JUL-11 1DJP 1 VERSN REVDAT 4 24-FEB-09 1DJP 1 VERSN REVDAT 3 01-APR-03 1DJP 1 JRNL REVDAT 2 18-FEB-00 1DJP 1 JRNL AUTHOR REVDAT 1 24-JAN-00 1DJP 0 JRNL AUTH E.ORTLUND,M.W.LACOUNT,K.LEWINSKI,L.LEBIODA JRNL TITL REACTIONS OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH JRNL TITL 2 DIAZO ANALOGUES OF GLUTAMINE AND ASPARAGINE RESULT IN JRNL TITL 3 UNEXPECTED COVALENT INHIBITIONS AND SUGGESTS AN UNUSUAL JRNL TITL 4 CATALYTIC TRIAD THR-TYR-GLU. JRNL REF BIOCHEMISTRY V. 39 1199 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10684596 JRNL DOI 10.1021/BI991797D REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 292804.770 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.7 REMARK 3 NUMBER OF REFLECTIONS : 46995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4726 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6563 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 7340 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4970 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 211 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.78000 REMARK 3 B22 (A**2) : 9.36000 REMARK 3 B33 (A**2) : -6.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.120 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 56.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PA REMARK 3 PARAMETER FILE 2 : WATER_REP.PARA REMARK 3 PARAMETER FILE 3 : DON.PAR REMARK 3 PARAMETER FILE 4 : DON_AS2.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.PARAM REMARK 3 TOPOLOGY FILE 3 : DON.TOP REMARK 3 TOPOLOGY FILE 4 : DON_AS2.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DJP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-00. REMARK 100 THE DEPOSITION ID IS D_1000010138. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-97 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50192 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 48.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.7 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 37.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 M AMMONIUM SULFATE, PH 6.4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.79000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.79000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.25500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.95500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.25500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.95500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 68.79000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.25500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.95500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 68.79000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.25500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.95500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 18340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 78.51000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 206.37000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 3034 CG DO2 B 4001 2.07 REMARK 500 OH TYR A 1034 CG DO2 A 4000 2.08 REMARK 500 OG1 THR B 3020 OE1 DO2 B 4001 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A1177 -54.91 73.51 REMARK 500 THR A1208 -102.21 23.09 REMARK 500 SER A1280 -158.57 -118.44 REMARK 500 HIS A1306 -118.05 58.90 REMARK 500 ILE B3177 -52.68 71.48 REMARK 500 THR B3208 -97.17 25.79 REMARK 500 SER B3280 -162.89 -118.25 REMARK 500 HIS B3306 -117.07 61.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 UPON REACTION OF 6-DIAZO-5-OXO-L-NORVALINE, A DIAZO REMARK 600 ANALOGUE OF GLUTAMINE, THE HET GROUP WAS TRANSFORMED REMARK 600 INTO THE COVALENTLY BOUND INHIBITOR, DO2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DO2 A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DO2 B 4001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PGA RELATED DB: PDB REMARK 900 NATIVE STRUCTURE WITH AMMONIUM SULFATE IONS INDUCING THE ACTIVE REMARK 900 CONFORMATION REMARK 900 RELATED ID: 1DJO RELATED DB: PDB DBREF 1DJP A 1008 1337 UNP P10182 ASPQ_PSES7 8 337 DBREF 1DJP B 3008 3337 UNP P10182 ASPQ_PSES7 8 337 SEQADV 1DJP ASN A 1111 UNP P10182 ASP 111 SEE REMARK 999 SEQADV 1DJP VAL A 1113 UNP P10182 THR 113 SEE REMARK 999 SEQADV 1DJP GLN A 1114 UNP P10182 LEU 114 SEE REMARK 999 SEQADV 1DJP LYS A 1115 UNP P10182 ASN 115 SEE REMARK 999 SEQADV 1DJP VAL A 1263 UNP P10182 LEU 263 SEE REMARK 999 SEQADV 1DJP VAL A 1264 UNP P10182 THR 264 SEE REMARK 999 SEQADV 1DJP GLN A 1269 UNP P10182 THR 269 SEE REMARK 999 SEQADV 1DJP ASN A 1273 UNP P10182 THR 273 SEE REMARK 999 SEQADV 1DJP ALA A 1317 UNP P10182 VAL 317 SEE REMARK 999 SEQADV 1DJP MET A 1318 UNP P10182 GLU 318 SEE REMARK 999 SEQADV 1DJP VAL A 1319 UNP P10182 LEU 319 SEE REMARK 999 SEQADV 1DJP THR A 1322 UNP P10182 VAL 322 SEE REMARK 999 SEQADV 1DJP ASN B 3111 UNP P10182 ASP 111 SEE REMARK 999 SEQADV 1DJP VAL B 3113 UNP P10182 THR 113 SEE REMARK 999 SEQADV 1DJP GLN B 3114 UNP P10182 LEU 114 SEE REMARK 999 SEQADV 1DJP LYS B 3115 UNP P10182 ASN 115 SEE REMARK 999 SEQADV 1DJP VAL B 3263 UNP P10182 LEU 263 SEE REMARK 999 SEQADV 1DJP VAL B 3264 UNP P10182 THR 264 SEE REMARK 999 SEQADV 1DJP GLN B 3269 UNP P10182 THR 269 SEE REMARK 999 SEQADV 1DJP ASN B 3273 UNP P10182 THR 273 SEE REMARK 999 SEQADV 1DJP ALA B 3317 UNP P10182 VAL 317 SEE REMARK 999 SEQADV 1DJP MET B 3318 UNP P10182 GLU 318 SEE REMARK 999 SEQADV 1DJP VAL B 3319 UNP P10182 LEU 319 SEE REMARK 999 SEQADV 1DJP THR B 3322 UNP P10182 VAL 322 SEE REMARK 999 SEQRES 1 A 330 LYS LEU ALA ASN VAL VAL ILE LEU ALA THR GLY GLY THR SEQRES 2 A 330 ILE ALA GLY ALA GLY ALA SER ALA ALA ASN SER ALA THR SEQRES 3 A 330 TYR GLN ALA ALA LYS VAL GLY VAL ASP LYS LEU ILE ALA SEQRES 4 A 330 GLY VAL PRO GLU LEU ALA ASP LEU ALA ASN VAL ARG GLY SEQRES 5 A 330 GLU GLN VAL MET GLN ILE ALA SER GLU SER ILE THR ASN SEQRES 6 A 330 ASP ASP LEU LEU LYS LEU GLY LYS ARG VAL ALA GLU LEU SEQRES 7 A 330 ALA ASP SER ASN ASP VAL ASP GLY ILE VAL ILE THR HIS SEQRES 8 A 330 GLY THR ASP THR LEU GLU GLU THR ALA TYR PHE LEU ASN SEQRES 9 A 330 LEU VAL GLN LYS THR ASP LYS PRO ILE VAL VAL VAL GLY SEQRES 10 A 330 SER MET ARG PRO GLY THR ALA MET SER ALA ASP GLY MET SEQRES 11 A 330 LEU ASN LEU TYR ASN ALA VAL ALA VAL ALA SER ASN LYS SEQRES 12 A 330 ASP SER ARG GLY LYS GLY VAL LEU VAL THR MET ASN ASP SEQRES 13 A 330 GLU ILE GLN SER GLY ARG ASP VAL SER LYS SER ILE ASN SEQRES 14 A 330 ILE LYS THR GLU ALA PHE LYS SER ALA TRP GLY PRO LEU SEQRES 15 A 330 GLY MET VAL VAL GLU GLY LYS SER TYR TRP PHE ARG LEU SEQRES 16 A 330 PRO ALA LYS ARG HIS THR VAL ASN SER GLU PHE ASP ILE SEQRES 17 A 330 LYS GLN ILE SER SER LEU PRO GLN VAL ASP ILE ALA TYR SEQRES 18 A 330 SER TYR GLY ASN VAL THR ASP THR ALA TYR LYS ALA LEU SEQRES 19 A 330 ALA GLN ASN GLY ALA LYS ALA LEU ILE HIS ALA GLY THR SEQRES 20 A 330 GLY ASN GLY SER VAL SER SER ARG VAL VAL PRO ALA LEU SEQRES 21 A 330 GLN GLN LEU ARG LYS ASN GLY THR GLN ILE ILE ARG SER SEQRES 22 A 330 SER HIS VAL ASN GLN GLY GLY PHE VAL LEU ARG ASN ALA SEQRES 23 A 330 GLU GLN PRO ASP ASP LYS ASN ASP TRP VAL VAL ALA HIS SEQRES 24 A 330 ASP LEU ASN PRO GLU LYS ALA ARG ILE LEU ALA MET VAL SEQRES 25 A 330 ALA MET THR LYS THR GLN ASP SER LYS GLU LEU GLN ARG SEQRES 26 A 330 ILE PHE TRP GLU TYR SEQRES 1 B 330 LYS LEU ALA ASN VAL VAL ILE LEU ALA THR GLY GLY THR SEQRES 2 B 330 ILE ALA GLY ALA GLY ALA SER ALA ALA ASN SER ALA THR SEQRES 3 B 330 TYR GLN ALA ALA LYS VAL GLY VAL ASP LYS LEU ILE ALA SEQRES 4 B 330 GLY VAL PRO GLU LEU ALA ASP LEU ALA ASN VAL ARG GLY SEQRES 5 B 330 GLU GLN VAL MET GLN ILE ALA SER GLU SER ILE THR ASN SEQRES 6 B 330 ASP ASP LEU LEU LYS LEU GLY LYS ARG VAL ALA GLU LEU SEQRES 7 B 330 ALA ASP SER ASN ASP VAL ASP GLY ILE VAL ILE THR HIS SEQRES 8 B 330 GLY THR ASP THR LEU GLU GLU THR ALA TYR PHE LEU ASN SEQRES 9 B 330 LEU VAL GLN LYS THR ASP LYS PRO ILE VAL VAL VAL GLY SEQRES 10 B 330 SER MET ARG PRO GLY THR ALA MET SER ALA ASP GLY MET SEQRES 11 B 330 LEU ASN LEU TYR ASN ALA VAL ALA VAL ALA SER ASN LYS SEQRES 12 B 330 ASP SER ARG GLY LYS GLY VAL LEU VAL THR MET ASN ASP SEQRES 13 B 330 GLU ILE GLN SER GLY ARG ASP VAL SER LYS SER ILE ASN SEQRES 14 B 330 ILE LYS THR GLU ALA PHE LYS SER ALA TRP GLY PRO LEU SEQRES 15 B 330 GLY MET VAL VAL GLU GLY LYS SER TYR TRP PHE ARG LEU SEQRES 16 B 330 PRO ALA LYS ARG HIS THR VAL ASN SER GLU PHE ASP ILE SEQRES 17 B 330 LYS GLN ILE SER SER LEU PRO GLN VAL ASP ILE ALA TYR SEQRES 18 B 330 SER TYR GLY ASN VAL THR ASP THR ALA TYR LYS ALA LEU SEQRES 19 B 330 ALA GLN ASN GLY ALA LYS ALA LEU ILE HIS ALA GLY THR SEQRES 20 B 330 GLY ASN GLY SER VAL SER SER ARG VAL VAL PRO ALA LEU SEQRES 21 B 330 GLN GLN LEU ARG LYS ASN GLY THR GLN ILE ILE ARG SER SEQRES 22 B 330 SER HIS VAL ASN GLN GLY GLY PHE VAL LEU ARG ASN ALA SEQRES 23 B 330 GLU GLN PRO ASP ASP LYS ASN ASP TRP VAL VAL ALA HIS SEQRES 24 B 330 ASP LEU ASN PRO GLU LYS ALA ARG ILE LEU ALA MET VAL SEQRES 25 B 330 ALA MET THR LYS THR GLN ASP SER LYS GLU LEU GLN ARG SEQRES 26 B 330 ILE PHE TRP GLU TYR HET DO2 A4000 10 HET DO2 B4001 10 HETNAM DO2 5,5-DIHYDROXY-6-OXO-L-NORLEUCINE FORMUL 3 DO2 2(C6 H11 N O5) FORMUL 5 HOH *211(H2 O) HELIX 1 1 GLY A 1040 VAL A 1048 1 9 HELIX 2 2 GLU A 1050 ALA A 1055 1 6 HELIX 3 3 ALA A 1066 ILE A 1070 5 5 HELIX 4 4 THR A 1071 SER A 1088 1 18 HELIX 5 5 GLY A 1099 ASP A 1101 5 3 HELIX 6 6 THR A 1102 GLN A 1114 1 13 HELIX 7 7 ASP A 1135 SER A 1148 1 14 HELIX 8 8 ASN A 1149 ARG A 1153 5 5 HELIX 9 9 HIS A 1207 SER A 1211 5 5 HELIX 10 10 ASP A 1214 ILE A 1218 5 5 HELIX 11 11 ASP A 1235 ASN A 1244 1 10 HELIX 12 12 VAL A 1263 ASN A 1273 1 11 HELIX 13 13 PRO A 1296 ASP A 1301 1 6 HELIX 14 14 ASN A 1309 MET A 1321 1 13 HELIX 15 15 ASP A 1326 TYR A 1337 1 12 HELIX 16 16 THR B 3020 GLY B 3023 5 4 HELIX 17 17 GLY B 3040 GLY B 3047 1 8 HELIX 18 18 VAL B 3048 ALA B 3052 5 5 HELIX 19 19 ALA B 3066 ILE B 3070 5 5 HELIX 20 20 THR B 3071 SER B 3088 1 18 HELIX 21 21 THR B 3102 GLN B 3114 1 13 HELIX 22 22 ASP B 3135 SER B 3148 1 14 HELIX 23 23 ASN B 3149 ARG B 3153 5 5 HELIX 24 24 HIS B 3207 SER B 3211 5 5 HELIX 25 25 ASP B 3235 ASN B 3244 1 10 HELIX 26 26 VAL B 3263 ASN B 3273 1 11 HELIX 27 27 PRO B 3296 ASP B 3301 1 6 HELIX 28 28 ASN B 3309 MET B 3321 1 13 HELIX 29 29 ASP B 3326 TRP B 3335 1 10 SHEET 1 A 8 ASN A1056 ILE A1065 0 SHEET 2 A 8 ASN A1011 GLY A1018 1 N VAL A1012 O ASN A1056 SHEET 3 A 8 GLY A1093 THR A1097 1 O GLY A1093 N VAL A1013 SHEET 4 A 8 ILE A1120 VAL A1123 1 N VAL A1121 O ILE A1094 SHEET 5 A 8 LEU A1158 VAL A1159 1 N LEU A1158 O ILE A1120 SHEET 6 A 8 GLU A1164 SER A1167 -1 N GLN A1166 O VAL A1159 SHEET 7 A 8 GLY A1190 VAL A1193 -1 O GLY A1190 N ILE A1165 SHEET 8 A 8 LYS A1196 TRP A1199 -1 O LYS A1196 N VAL A1193 SHEET 1 B 2 SER A1172 LYS A1173 0 SHEET 2 B 2 PHE A1182 LYS A1183 -1 N LYS A1183 O SER A1172 SHEET 1 C 4 VAL A1224 TYR A1228 0 SHEET 2 C 4 ALA A1248 GLY A1253 1 O ALA A1248 N ASP A1225 SHEET 3 C 4 GLN A1276 SER A1281 1 O GLN A1276 N LEU A1249 SHEET 4 C 4 VAL A1303 VAL A1304 1 O VAL A1303 N ARG A1279 SHEET 1 D 8 ALA B3055 ILE B3065 0 SHEET 2 D 8 ALA B3010 GLY B3018 1 O ALA B3010 N ASN B3056 SHEET 3 D 8 GLY B3093 THR B3097 1 O GLY B3093 N VAL B3013 SHEET 4 D 8 ILE B3120 VAL B3123 1 N VAL B3121 O ILE B3094 SHEET 5 D 8 VAL B3157 VAL B3159 1 O LEU B3158 N VAL B3122 SHEET 6 D 8 GLU B3164 SER B3167 -1 N GLN B3166 O VAL B3159 SHEET 7 D 8 GLY B3190 VAL B3193 -1 O GLY B3190 N ILE B3165 SHEET 8 D 8 LYS B3196 TRP B3199 -1 O LYS B3196 N VAL B3193 SHEET 1 E 2 SER B3172 LYS B3173 0 SHEET 2 E 2 PHE B3182 LYS B3183 -1 N LYS B3183 O SER B3172 SHEET 1 F 4 VAL B3224 TYR B3228 0 SHEET 2 F 4 ALA B3248 GLY B3253 1 O ALA B3248 N ASP B3225 SHEET 3 F 4 GLN B3276 SER B3281 1 O GLN B3276 N LEU B3249 SHEET 4 F 4 VAL B3303 VAL B3304 1 O VAL B3303 N ARG B3279 LINK OG1 THR A1020 CD DO2 A4000 1555 1555 1.46 LINK OH TYR A1034 CD DO2 A4000 1555 1555 1.46 LINK OG1 THR B3020 CD DO2 B4001 1555 1555 1.44 LINK OH TYR B3034 CD DO2 B4001 1555 1555 1.11 LINK OG1 THR A1020 CG DO2 A4000 1555 1555 1.85 LINK OG1 THR B3020 CG DO2 B4001 1555 1555 1.65 SITE 1 AC1 11 GLY A1019 THR A1020 TYR A1034 ALA A1066 SITE 2 AC1 11 SER A1067 GLU A1068 GLY A1099 THR A1100 SITE 3 AC1 11 ASP A1101 SER A1125 GLU B3294 SITE 1 AC2 12 SER A1258 GLU A1294 GLY B3019 THR B3020 SITE 2 AC2 12 TYR B3034 ALA B3066 SER B3067 GLU B3068 SITE 3 AC2 12 GLY B3099 THR B3100 ASP B3101 SER B3125 CRYST1 78.510 135.910 137.580 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012737 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007358 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007268 0.00000